Concert Pharmaceuticals, Inc. Executive Bonus Program Summary
Concert Pharmaceuticals, Inc. has an executive bonus program where the board of directors may award bonuses to named executive officers at its discretion. Bonuses are typically based on annual targets and specific corporate goals set by the board. After a performance review, management may propose bonus amounts to the Compensation Committee or the board, but the board has the final authority to decide eligibility and bonus amounts.
Exhibit 10.19
SUMMARY OF EXECUTIVE BONUS PROGRAM
The board of directors (the “Board”) of Concert Pharmaceuticals, Inc. (the “Company”) may, in its discretion, award bonuses to the Company’s named executive officers from time to time. These bonuses have typically been based on annual bonus targets and sets of specified corporate goals for the Company’s named executive officers established by the Board, followed by a performance review by the Board to determine the attainment of such goals. The Company’s management may propose bonus awards to the Compensation Committee of the Board or the Board primarily based on such review process. The Board makes the final determination of the eligibility requirements for and the amount of such bonus awards.
